Feb 29 |
Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price
|
Feb 28 |
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet
|
Feb 28 |
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
|
Feb 28 |
Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ...
|
Feb 27 |
Zentalis Pharmaceuticals GAAP EPS of -$4.47 beats by $0.06
|
Feb 27 |
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
|
Feb 14 |
Down -19.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Zentalis Pharmaceuticals, Inc. (ZNTL)
|
Feb 13 |
Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference
|
Feb 8 |
What Makes Zentalis Pharmaceuticals, Inc. (ZNTL) a New Buy Stock
|
Feb 7 |
Zentalis Pharmaceuticals: Azenosertib Continues To Impress
|